Autor: |
IGNAT, ANDREEA, ALEXANDRU, OANA, NICULAE, LAURA, VIŞAN, MIHAELA FLORENTINA, LEÞI, MARIA MÃDÃLINA, BUDIŞTEANU, BOGDAN |
Předmět: |
|
Zdroj: |
Romanian Journal of Child & Adolescent Psychiatry; Jan-Jun2020, Vol. 8 Issue 1/2, p32-40, 9p |
Abstrakt: |
The world of psychiatrists and pharmacologists is increasingly striving to find new methods of intervention and treatment to improve the quality of life of patients with chronic psychiatric diseases and also to make them more functional and better integrated into society. Thus, more and more molecules are discovered and approved by the Food and Drug Administration in order to achieve these purposes. In this paper, we made a descriptive research of four of the newest antipsychotics, randomly chosen. We selected 38 articles and focused on the forms of presentation, the mechanism of action, the side effects, the drug interaction and the tolerance profile. Thus, we intend to offer new perspectives on how diseases such schizophrenia, treatment-resistant depression, bipolar disorder can be psychopharmacologically approached. The Authors declare that there is no conflict of interest. [ABSTRACT FROM AUTHOR] |
Databáze: |
Complementary Index |
Externí odkaz: |
|